Immunocore Holdings plc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
IMCR Nasdaq 2836 www.immunocore.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Immunocore Holdings plc

Immunocore Hits Enrollment Target in Kimmtrak Label Expansion Study - Sep 15th, 2026 9:22 am
Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma - Sep 14th, 2026 5:00 am
Immunocore to present at upcoming investor conferences - Sep 1st, 2026 5:00 am
Will Kimmtrak Continue to Aid IMCR's Growth Through the Rest of 2026? - Aug 25th, 2026 9:07 am
IMCR Q2 Revenues Climb 18.3% as Kimmtrak Demand Helps Offset EPS Miss - Aug 10th, 2026 9:39 am
Immunocore's Q2 Earnings Miss Estimates, Kimmtrak Aids Y/Y Revenues - Aug 7th, 2026 11:27 am
Wall Street Analysts See a 77.91% Upside in Immunocore (IMCR): Can the Stock Really Move This High? - Aug 7th, 2026 7:55 am
How Strong H1 Profits and Kimtrak Survival Data At Immunocore (IMCR) Have Changed Its Investment Story - Aug 7th, 2026 2:15 am
Immunocore Q2 Earnings Call Highlights - Aug 6th, 2026 1:04 pm
Immunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Kimtrak Growth and Pipeline ... - Aug 6th, 2026 1:02 pm
Immunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Strong Kimtrak Growth and ... - Aug 6th, 2026 11:06 am
Immunocore reports second quarter financial results and provides a business update - Aug 6th, 2026 5:00 am
Immunocore to report second quarter 2026 financial results and host call on August 6, 2026 - Jul 30th, 2026 5:00 am
How Immunocore Is Expanding Beyond Its Rare-Cancer Drug Kimmtrak - Jul 27th, 2026 9:54 am
Is Immunocore Stock Attractive After Kimmtrak's Strong Sales Growth? - Jul 27th, 2026 9:53 am
Is Immunocore Holdings (IMCR) Undervalued After Its Recent Share Price Rebound? - Jul 9th, 2026 9:11 am
AtaiBeckley Completes VLS-01 Dosing in Phase IIb Depression Study - Jul 7th, 2026 8:10 am
NVS Gains EC Approval for SMA Therapy Itvisma in Broad Population - Jul 2nd, 2026 12:13 pm
Vertex Gets FDA Nod for Expanded Use of Casgevy in SCD & TDT - Jul 2nd, 2026 8:42 am
CPRX's Agamree Shows Potential Beyond DMD After Positive Phase I Data - Jul 2nd, 2026 7:34 am